HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selective lowering of synapsins induced by oligomeric α-synuclein exacerbates memory deficits.

Abstract
Mounting evidence indicates that soluble oligomeric forms of amyloid proteins linked to neurodegenerative disorders, such as amyloid-β (Aβ), tau, or α-synuclein (αSyn) might be the major deleterious species for neuronal function in these diseases. Here, we found an abnormal accumulation of oligomeric αSyn species in AD brains by custom ELISA, size-exclusion chromatography, and nondenaturing/denaturing immunoblotting techniques. Importantly, the abundance of αSyn oligomers in human brain tissue correlated with cognitive impairment and reductions in synapsin expression. By overexpressing WT human αSyn in an AD mouse model, we artificially enhanced αSyn oligomerization. These bigenic mice displayed exacerbated Aβ-induced cognitive deficits and a selective decrease in synapsins. Following isolation of various soluble αSyn assemblies from transgenic mice, we found that in vitro delivery of exogenous oligomeric αSyn but not monomeric αSyn was causing a lowering in synapsin-I/II protein abundance. For a particular αSyn oligomer, these changes were either dependent or independent on endogenous αSyn expression. Finally, at a molecular level, the expression of synapsin genes SYN1 and SYN2 was down-regulated in vivo and in vitro by αSyn oligomers, which decreased two transcription factors, cAMP response element binding and Nurr1, controlling synapsin gene promoter activity. Overall, our results demonstrate that endogenous αSyn oligomers can impair memory by selectively lowering synapsin expression.
AuthorsMegan E Larson, Susan J Greimel, Fatou Amar, Michael LaCroix, Gabriel Boyle, Mathew A Sherman, Hallie Schley, Camille Miel, Julie A Schneider, Rakez Kayed, Fabio Benfenati, Michael K Lee, David A Bennett, Sylvain E Lesné
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 114 Issue 23 Pg. E4648-E4657 (06 06 2017) ISSN: 1091-6490 [Electronic] United States
PMID28533388 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Creb1 protein, mouse
  • Cyclic AMP Response Element-Binding Protein
  • FAM107A protein, human
  • Nr4a2 protein, mouse
  • Nuclear Proteins
  • Nuclear Receptor Subfamily 4, Group A, Member 2
  • Recombinant Proteins
  • SNCA protein, human
  • Synapsins
  • alpha-Synuclein
Topics
  • Alzheimer Disease (etiology, genetics, metabolism)
  • Animals
  • Brain (metabolism)
  • Cognition (physiology)
  • Cyclic AMP Response Element-Binding Protein (metabolism)
  • Disease Models, Animal
  • Genes, Tumor Suppressor
  • Humans
  • Memory Disorders (etiology, genetics, metabolism)
  • Mice
  • Mice, Transgenic
  • Nuclear Proteins
  • Nuclear Receptor Subfamily 4, Group A, Member 2 (metabolism)
  • Protein Structure, Quaternary
  • Recombinant Proteins (chemistry, genetics, metabolism)
  • Solubility
  • Synapsins (genetics, metabolism)
  • alpha-Synuclein (chemistry, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: